Home » Topics » Regulatory » Patents

Patents
RSS

Bluebird bio divulges non-natural T cells for cancer

Nov. 26, 2020

Incyte synthesizes CDK2/cyclin E inhibitors

Nov. 26, 2020

Aclaris Therapeutics identifies new JAK inhibitors

Nov. 26, 2020

Constellation Pharmaceuticals synthesizes TREX1 inhibitors

Nov. 26, 2020

Kinnate Biopharma patents Raf kinase inhibitors

Nov. 26, 2020

BioWorld MedTech Patent Highlights: Week 47

From Current Patent Gazette

Nov. 25, 2020

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Humabs BioMed divulges antibodies targeting influenza A HA protein

Nov. 25, 2020

Merck & Co. describes new nicotinic alpha7 receptor PAMs

Nov. 25, 2020

Snap Bio presents new Pim-1 and/or Pim-3 kinase inhibitors

Nov. 25, 2020

Incyte discloses new CDK2/cyclin E inhibitors

Nov. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...